Outcome Of MicroPulse® Transscleral Photocoagulation In Different Types Of Glaucoma

Outcome Of MicroPulse® Transscleral Photocoagulation In Different Types Of Glaucoma

Ahmed Al Habash,1 Adel Salah AlAhmadi2 1Department of Ophthalmology, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 2Ministry of Health, Madinah, Saudi ArabiaCorrespondence: Ahmed Al HabashDepartment of Ophthalmology, King Fahd Hospital of the Uni...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Al Habash A, AlAhmadi AS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
glaucoma
ciliary body
transscleral cyclophotocoagulation
micropulse diode laser.
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/dc96acf46c46497fa38039ee52be4c43
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dc96acf46c46497fa38039ee52be4c43
record_format dspace
spelling oai:doaj.org-article:dc96acf46c46497fa38039ee52be4c432021-12-02T11:57:38ZOutcome Of MicroPulse® Transscleral Photocoagulation In Different Types Of Glaucoma1177-5483https://doaj.org/article/dc96acf46c46497fa38039ee52be4c432019-12-01T00:00:00Zhttps://www.dovepress.com/outcome-of-micropulsereg-transscleral-photocoagulation-in-different-ty-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Ahmed Al Habash,1 Adel Salah AlAhmadi2 1Department of Ophthalmology, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 2Ministry of Health, Madinah, Saudi ArabiaCorrespondence: Ahmed Al HabashDepartment of Ophthalmology, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi ArabiaEmail ahmedalhabash@gmail.comPurpose: To evaluate the safety and efficacy of MicroPulse® transscleral cyclophotocoagulation (μP-TSCPC) up to 24-months follow-up using a standardized fixed protocol in patients with various types of glaucoma.Methods: Prospective, nonrandomized, non-comparative interventional case series of μP-TSCPC performed by a single glaucoma surgeon at tertiary hospitals between May 2017 and May 2019.Results: A total of 71 eyes of 68 patients (39 males, 29 females) aged 60.0 years (13–89 years) were treated with μP-TSCPC. The most common diagnosis was neovascular glaucoma. The safety index of corrected distance visual acuity (CDVA) was 1.0, i.e. there was no significant change in CDVA postoperatively compared to baseline CDVA. The median baseline IOP was 35.0 mmHg (21.0–70.0 mmHg), which was reduced to 16 mmHg (8–32 mmHg) at 12 months/last follow-up postoperatively (p<0.001, Wilcoxon signed-rank test). The median reduction in IOP was 52% (0.0–89%) at 12 months/last follow-up postoperatively compared to baseline. The median number of medications was 5 (3–5) at baseline compared to 4 (2–4) at 12 months/last follow-up postoperatively (p<0.001, Wilcoxon signed-rank test). The percent of eyes treated with systemic glaucoma medication was 62% (44) at baseline compared to 0% (0) at 12 months/last follow-up postoperatively. The postoperative surgical success of 90%, 91.4%, and 95.7% at 2 weeks, 3 months, and 6 months respectively then remains unchanged. No significant adverse events or complications were observed.Conclusion: μP-TSCPC demonstrated good efficacy and safety profiles with minimal vision-threatening complications in treating a variety of glaucoma types.Keywords: glaucoma, ciliary body, transscleral cyclophotocoagulation, MicroPulse diode laser  Al Habash AAlAhmadi ASDove Medical Pressarticleglaucomaciliary bodytransscleral cyclophotocoagulationmicropulse diode laser.OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 13, Pp 2353-2360 (2019)
institution DOAJ
collection DOAJ
language EN
topic glaucoma
ciliary body
transscleral cyclophotocoagulation
micropulse diode laser.
Ophthalmology
RE1-994
spellingShingle glaucoma
ciliary body
transscleral cyclophotocoagulation
micropulse diode laser.
Ophthalmology
RE1-994
Al Habash A
AlAhmadi AS
Outcome Of MicroPulse® Transscleral Photocoagulation In Different Types Of Glaucoma
description Ahmed Al Habash,1 Adel Salah AlAhmadi2 1Department of Ophthalmology, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 2Ministry of Health, Madinah, Saudi ArabiaCorrespondence: Ahmed Al HabashDepartment of Ophthalmology, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi ArabiaEmail ahmedalhabash@gmail.comPurpose: To evaluate the safety and efficacy of MicroPulse® transscleral cyclophotocoagulation (μP-TSCPC) up to 24-months follow-up using a standardized fixed protocol in patients with various types of glaucoma.Methods: Prospective, nonrandomized, non-comparative interventional case series of μP-TSCPC performed by a single glaucoma surgeon at tertiary hospitals between May 2017 and May 2019.Results: A total of 71 eyes of 68 patients (39 males, 29 females) aged 60.0 years (13–89 years) were treated with μP-TSCPC. The most common diagnosis was neovascular glaucoma. The safety index of corrected distance visual acuity (CDVA) was 1.0, i.e. there was no significant change in CDVA postoperatively compared to baseline CDVA. The median baseline IOP was 35.0 mmHg (21.0–70.0 mmHg), which was reduced to 16 mmHg (8–32 mmHg) at 12 months/last follow-up postoperatively (p<0.001, Wilcoxon signed-rank test). The median reduction in IOP was 52% (0.0–89%) at 12 months/last follow-up postoperatively compared to baseline. The median number of medications was 5 (3–5) at baseline compared to 4 (2–4) at 12 months/last follow-up postoperatively (p<0.001, Wilcoxon signed-rank test). The percent of eyes treated with systemic glaucoma medication was 62% (44) at baseline compared to 0% (0) at 12 months/last follow-up postoperatively. The postoperative surgical success of 90%, 91.4%, and 95.7% at 2 weeks, 3 months, and 6 months respectively then remains unchanged. No significant adverse events or complications were observed.Conclusion: μP-TSCPC demonstrated good efficacy and safety profiles with minimal vision-threatening complications in treating a variety of glaucoma types.Keywords: glaucoma, ciliary body, transscleral cyclophotocoagulation, MicroPulse diode laser  
format article
author Al Habash A
AlAhmadi AS
author_facet Al Habash A
AlAhmadi AS
author_sort Al Habash A
title Outcome Of MicroPulse® Transscleral Photocoagulation In Different Types Of Glaucoma
title_short Outcome Of MicroPulse® Transscleral Photocoagulation In Different Types Of Glaucoma
title_full Outcome Of MicroPulse® Transscleral Photocoagulation In Different Types Of Glaucoma
title_fullStr Outcome Of MicroPulse® Transscleral Photocoagulation In Different Types Of Glaucoma
title_full_unstemmed Outcome Of MicroPulse® Transscleral Photocoagulation In Different Types Of Glaucoma
title_sort outcome of micropulse® transscleral photocoagulation in different types of glaucoma
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/dc96acf46c46497fa38039ee52be4c43
work_keys_str_mv AT alhabasha outcomeofmicropulseregtransscleralphotocoagulationindifferenttypesofglaucoma
AT alahmadias outcomeofmicropulseregtransscleralphotocoagulationindifferenttypesofglaucoma
_version_ 1718394839252336640

Ejemplares similares